Century Therapeutics, Inc. Common Stock (NASDAQ: IPSC) last traded at $2.07, up 2.48% on the session. The quote above updates while this page is open; the figures below are drawn from Century Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Century Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker IPSC. Its market capitalisation is $374.83 million.
Valuation measures for Century Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $374.83M |
|---|---|
| Enterprise value | $379.84M |
| Price / sales | 3.26 |
| Price / book | 1.61 |
| Beta | 2.07 |
Trailing-twelve-month figures tagged in Century Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $114.90M |
|---|---|
| Net income (TTM) | -$109.79M |
| Operating margin | -101.82% |
| Return on equity | -47.25% |
| Cash | $49.64M |
Range and volume for IPSC over the past 52 weeks.
| 52-week high | $3.04 |
|---|---|
| 52-week low | $0.435 |
| Volume | 330.0K |
| Average volume | 1.20M |
| Previous close | $2.02 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.